Response to Anti-TNF Linked to CV Risk in RA (CME/CE)

(MedPage Today) -- With good response to treatment, risk of acute coronary syndrome in RA patients fell by half
via Response to Anti-TNF Linked to CV Risk in RA (CME/CE)
by